scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1365-2990.2005.00666.X |
P698 | PubMed publication ID | 16150120 |
P2093 | author name string | Saunders D | |
Gentleman SM | |||
Bresciani L | |||
Jen LS | |||
Jen A | |||
Walsh DT | |||
Manca MF | |||
P2860 | cites work | Retinal ganglion cell survival requirements: a major but transient dependence on Müller glia during development | Q48298602 |
Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes | Q48559540 | ||
Nitric oxide synthase in developing retinas and after optic tract section | Q48680849 | ||
Glutamate uptake in mammalian retinal glia is voltage- and potassium-dependent | Q48969244 | ||
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment | Q49050987 | ||
Retinal ganglion cell survival and neurite regeneration in vitro after cell death period are dependent upon target derived trophic factor and retinal glial factor(s). | Q52021886 | ||
Activation of microglial cells by beta-amyloid protein and interferon-gamma. | Q53202007 | ||
Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: identification of a cellular activation mechanism. | Q53348339 | ||
Alzheimer's peptide kills cells of retina in vivo | Q57550941 | ||
Inflammation and Alzheimer's disease | Q28138617 | ||
Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice | Q28345644 | ||
Inhibition of Alzheimer's beta-amyloid induced vasoactivity and proinflammatory response in microglia by a cGMP-dependent mechanism | Q28374458 | ||
Beta-amyloid-induced glial expression of both pro- and anti-inflammatory cytokines in cerebral cortex of aged transgenic Tg2576 mice with Alzheimer plaque pathology | Q30658083 | ||
Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease | Q34386095 | ||
Retinal ganglion cell shrinkage in glaucoma | Q34778525 | ||
Retinal ganglion cell death in experimental glaucoma | Q35313813 | ||
beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease. | Q40384274 | ||
Amyloid beta-protein precursor: new clues to the genesis of Alzheimer's disease | Q40588457 | ||
What do retinal müller (glial) cells do for their neuronal 'small siblings'? | Q40713038 | ||
TGF-beta 1 is an organizer of responses to neurodegeneration | Q40810993 | ||
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. | Q40946540 | ||
Mechanisms of neuronal degeneration in Alzheimer's disease | Q40986730 | ||
Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils | Q41173971 | ||
Amyloid, the presenilins and Alzheimer's disease | Q41433661 | ||
Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice | Q41738653 | ||
Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease | Q41751577 | ||
Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage | Q42471112 | ||
A three-group classification of rat retinal ganglion cells: histological and physiological studies | Q43481968 | ||
Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease | Q43736972 | ||
Amyloid-beta peptide is toxic to neurons in vivo via indirect mechanisms. | Q44038214 | ||
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. | Q46006000 | ||
All-D-enantiomers of beta-amyloid exhibit similar biological properties to all-L-beta-amyloids. | Q46031773 | ||
Similarities between beta amyloid peptides 1-40 and 40-1: effects on aggregation, toxicity in vitro, and injection in young and aged rats | Q48176189 | ||
A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced | Q48179910 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 491-502 | |
P577 | publication date | 2005-10-01 | |
P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
P1476 | title | Amyloid beta peptide causes chronic glial cell activation and neuro-degeneration after intravitreal injection | |
P478 | volume | 31 |
Q46212337 | Acute and chronic effects of intravitreally injected beta-amyloid on the neurotransmitter system in the retina |
Q48255634 | Alterations in presenilin 1 processing by amyloid-beta peptide in the rat retina |
Q26739839 | Amyloidosis in Retinal Neurodegenerative Diseases |
Q88813187 | Association of Anticholinergic Drug Use With Risk for Late Age-Related Macular Degeneration |
Q35845240 | Axonal Terminals Exposed to Amyloid-β May Not Lead to Pre-Synaptic Axonal Damage |
Q47579780 | Characterisation of amyloid-induced inflammatory responses in the rat retina |
Q33702093 | Differential effects of amyloid-β peptide aggregation status on in vivo retinal neurotoxicity |
Q37257692 | Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons |
Q36074920 | Gemfibrozil, a lipid lowering drug, inhibits the activation of primary human microglia via peroxisome proliferator-activated receptor β. |
Q37236088 | Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the rat |
Q37530061 | Immunotherapeutic efficiency of a tetravalent Aβ1-15 vaccine in APP/PS1 transgenic mice as mouse model for Alzheimer's disease |
Q37655126 | In vivo diffusion tensor imaging of amyloid-β-induced white matter damage in mice |
Q37626384 | Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration |
Q48206372 | Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina |
Q41997847 | Neurodegenerative diseases of the retina and potential for protection and recovery |
Q41938308 | PPAR-gamma, Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches |
Q34764098 | Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation |
Q37461113 | The Alzheimer's-related amyloid beta peptide is internalised by R28 neuroretinal cells and disrupts the microtubule associated protein 2 (MAP-2). |
Q33702571 | The complexities underlying age-related macular degeneration: could amyloid beta play an important role? |